Mithra Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.1%.

Top 22 shareholders own 53.54% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15.6%	Francois Fornieri	10,809,882	€2.4m	0%	no data
14.5%	Armistice Capital LLC	10,000,000	€2.2m	0%	0.06%
7.94%	Noshaq S.A.	5,488,251	€1.2m	0%	100.0%
4.31%	Alychlo NV	2,975,928	€659.2k	0%	0.18%
3.6%	Goldman Sachs Group, Investment Banking and Securities Investments	2,489,759	€551.5k	0%	no data
2.38%	Bart Versluys	1,641,407	€363.6k	0%	no data
2.16%	Marc Armand Alice Andre Coucke	1,495,481	€331.2k	0%	no data
1.21%	AXA Investment Managers S.A.	832,944	€184.5k	0%	no data
1%	Selva Luxembourg S.A.	689,655	€152.8k	0%	no data
0.52%	BNPP Asset Management Holding	359,750	€79.7k	0%	no data
0.16%	BNP Paribas Asset Management Europe	111,919	€24.8k	0%	no data
0.067%	Van Rompay Management Bvba	46,125	€10.2k	0%	no data
0.042%	Valerie Gordenne	29,000	€6.4k	0%	no data
0.029%	Jean-Michel Foidart	20,370	€4.5k	0%	no data
0.0081%	Qqm Fund Management AB	5,575	€1.2k	0%	no data
0.0042%	Dimensional Fund Advisors LP	2,925	€647.5	0%	no data
0.0024%	Assenagon Asset Management S.A.	1,626	€359.7	0%	no data
0.0014%	Pictet Asset Management Limited	932	€206.7	0%	no data
0.0011%	Ajit S. Shetty	780	€173.0	0%	no data
0.00074%	State Street Global Advisors, Inc.	508	€113.3	12.4%	no data
0.00005%	Benjamin Brands	35	€7.7	0%	no data
0.00004%	Jean-Manuel Fontaine	28	€6.1	0%	no data